Letter to the Editor
Copyright ©The Author(s) 2024.
World J Stem Cells. Sep 26, 2024; 16(9): 846-853
Published online Sep 26, 2024. doi: 10.4252/wjsc.v16.i9.846
Table 2 Mesenchymal stem cell derivatives for treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
Ref.
Cell source
Secretome
Model
Disease
Function and mechanism
Kang et al[24]Human UC-MSC-EV-Mouse/HepG2 and AML12 cellsNASHNrf2/NQO-1 antioxidant signaling pathway
Yang et al[25]Human UC-MSC-EVCAMKK1Mouse/hepatic cellsNAFLDCAMKK1-mediated lipid homoeostasis regulation
Chen et al[30]MSC-sEVRNF31MouseNAFLDRegulation of mitochondrial homeostasis
Du et al[26]Human UC-MSC-ExoMiRNA-24-3pMouse/hepatocytesNAFLDMiR-24-3p directly targeted Kelch-like ECH-associated protein 1, and suppressed its expression
Restrained lipid accumulation, ROS generation, and inflammation
Niu et al[27]AD-MSC-EVMiRNA-223-3pMouse/hepatocytesNAFLDMiR-223-3p displayed suppressive effects on lipid accumulation and liver fibrosis through E2F1 inhibition
Cheng et al[28]Human UC-MSC-ExoMiRNA-627-5pRat/L-02 cellsNAFLDMiR-627-5p improved glucose and lipid metabolism and alleviated liver damage by repressing FTO expression
El-Derany et al[29]BM-MSC-ExoMiRNA-96-5pMouseNASHCaspase-2 signaling inhibition
Tawfeek and Kasem[20]Curcumin-preconditioned MSC-Exo-Mouse/HepG2 cellsNASHRegulated inflammatory, oxidative stress, and mitochondrial-dependent apoptosis-associated ASK-JNK-BAX genes
Kim et al[21]Pan-peroxisome proliferator-activated receptor agonist-primed induced MSC-EV-MouseNASHReduced steatotic changes and ameliorated ER stress and mitochondiral oxidative stress induced by inflammation
Zhang et al[23]MSC-sEV-MouseNASHPolarized pro-fibrotic M2 macrophages without exacerbating liver fibrosis
Yang et al[31]MSCs conditional medium-Mouse/L-02 cellsNAFLDImproved mitochondrial function and alleviated inflammation and apoptosis by regulating SIRT1